gemfibrozil has been researched along with Tuberculosis, Pulmonary in 1 studies
Tuberculosis, Pulmonary: MYCOBACTERIUM infections of the lung.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Gemfibrozil is a RORγ inhibitor that was inactive against Mtb cells." | 1.38 | Is RORγ a therapeutic target for treating Mycobacterium tuberculosis infections? ( Baures, PW, 2012) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Baures, PW | 1 |
1 other study available for gemfibrozil and Tuberculosis, Pulmonary
| Article | Year |
|---|---|
Is RORγ a therapeutic target for treating Mycobacterium tuberculosis infections?
Topics: Gemfibrozil; Humans; Macrophages; Mycobacterium tuberculosis; Receptors, Retinoic Acid; Retinoic Aci | 2012 |